Varian Medical Systems, Inc. (NYSE:VAR) EVP Kolleen T. Kennedy sold 699 shares of the firm’s stock in a transaction that occurred on Monday, March 12th. The stock was sold at an average price of $126.47, for a total transaction of $88,402.53. Following the sale, the executive vice president now owns 27,361 shares in the company, valued at approximately $3,460,345.67. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.
Varian Medical Systems, Inc. (NYSE:VAR) remained flat at $$126.55 during trading hours on Monday. The company had a trading volume of 380,487 shares, compared to its average volume of 749,387. The company has a market cap of $11,570.00, a PE ratio of 34.67, a P/E/G ratio of 3.67 and a beta of 0.85. Varian Medical Systems, Inc. has a 12 month low of $86.93 and a 12 month high of $130.29.
Varian Medical Systems (NYSE:VAR) last posted its quarterly earnings results on Wednesday, January 24th. The medical equipment provider reported $1.06 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.00 by $0.06. Varian Medical Systems had a net margin of 4.27% and a return on equity of 27.13%. The company had revenue of $678.50 million for the quarter, compared to the consensus estimate of $633.96 million. During the same quarter last year, the firm posted $1.09 earnings per share. Varian Medical Systems’s revenue was up 12.8% on a year-over-year basis. equities research analysts predict that Varian Medical Systems, Inc. will post 4.31 earnings per share for the current fiscal year.
A number of analysts recently issued reports on the stock. BTIG Research restated a “hold” rating on shares of Varian Medical Systems in a research report on Sunday, January 28th. Zacks Investment Research raised shares of Varian Medical Systems from a “sell” rating to a “hold” rating in a research note on Monday, January 29th. Barrington Research raised shares of Varian Medical Systems from a “market perform” rating to an “outperform” rating and set a $130.00 price target on the stock in a research note on Thursday, January 25th. ValuEngine raised shares of Varian Medical Systems from a “hold” rating to a “buy” rating in a research note on Thursday, March 1st. Finally, TheStreet downgraded shares of Varian Medical Systems from a “b+” rating to a “c” rating in a research note on Monday, February 12th. Three equities research analysts have rated the stock with a sell rating, seven have given a hold rating and four have given a buy rating to the company. The company currently has an average rating of “Hold” and a consensus price target of $108.44.
TRADEMARK VIOLATION NOTICE: “Varian Medical Systems, Inc. (VAR) EVP Kolleen T. Kennedy Sells 699 Shares” was originally reported by American Banking News and is owned by of American Banking News. If you are viewing this piece on another publication, it was illegally stolen and republished in violation of U.S. and international copyright and trademark law. The correct version of this piece can be viewed at https://www.americanbankingnews.com/2018/03/12/varian-medical-systems-inc-var-evp-kolleen-t-kennedy-sells-699-shares.html.
About Varian Medical Systems
Varian Medical Systems, Inc is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy.
Receive News & Ratings for Varian Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varian Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.